ASPIRE HEALTH PARTNERS INC — History
CCN 104067 | 3-year financial timeline | COVID resilience: 52/100
🛡️ Public data only — no PHI permitted on this instance.
$103M
Latest Revenue (FY2022)
+1.8%
Revenue CAGR (3yr)
-0.3%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $99M | $97M | $103M | +5.2% | +1.8% |
| Operating Expenses | $99M | $97M | $103M | +6.4% | +1.8% |
| Operating Margin | -0.3% | 0.8% | -0.3% | -135.2% | +0.0% |
| Net Income | $-0M | $1M | $-0M | -137.0% | +0.0% |
| Licensed Beds | 90 | 90 | 90 | +0.0% | +0.0% |
| Total Patient Days | 14,261 | 14,795 | 15,601 | +5.4% | +4.6% |
| Medicare Day % | 17% | 16% | 11% | -31.9% | -18.5% |
| Medicaid Day % | nan% | nan% | nan% | +nan% | +nan% |
COVID Impact & Recovery
Resilience Score: 52/100 — Stressed — slow recovery from COVID
Revenue recovery from FY2020 to FY2022: +3.6% ($99M → $103M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+1.8%
This Hospital
+7.6%
State Avg
Latest Margin
-0.3%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $104M | -0.3% |
| FY2024 (proj) | $106M | -0.2% |
| FY2025 (proj) | $108M | -0.2% |